Stocksigma LogoStocksigma Logo

Adisoft Technologies Reports Zero Deviation in Q2FY27 IPO Proceeds Utilization

CARE Ratings confirmed zero deviation in Adisoft Technologies' IPO proceeds utilization for the quarter ended 30th Sep'26

Adisoft Technologies Reports Zero Deviation in Q2FY27 IPO Proceeds Utilization

Adisoft Technologies Ltd · Others (Uncategorized) · 05 Nov 2026, 11:23 pm

Adisoft Technologies Reports Zero Deviation in Q2FY27 IPO Proceeds Utilization CARE Ratings confirmed zero deviation in Adisoft Technologies' IPO proceeds utilization for the quarter ended 30th Sep'26. Out of total issue proceeds of ₹74.10 crore, the company utilized ₹13.04 crore during Q2FY27, bringing cumulative deployment to ₹40.16 crore. Key disbursements included ₹10.00 crore toward full debt repayment and ₹2.90 crore for new factory capex. Unutilized funds of ₹33.94 crore remain parked primarily in fixed deposits with Axis Bank. An issue-expense surplus of ₹1.43 crore was reallocated to General Corporate Purposes per prospectus terms.

Original exchange filing (PDF)

More announcements from Adisoft Technologies Ltd

All Adisoft Technologies Ltd announcements